CorFlow Therapeutics AG Funding: $60M Raised, Series B
CorFlow Therapeutics AG is based in Baar, Switzerland. It has raised $60M in total funding. Latest round: Series B.
CorFlow Therapeutics AG funding overview
CorFlow Therapeutics AG is based in Baar, Switzerland. CorFlow Therapeutics AG has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for CorFlow Therapeutics AG runs through 2024; nothing later has been disclosed. Investors on record include Broadview Ventures, Panakes Partners, 415 Capital, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners and 4 others. 10 distinct backers are named across the disclosed rounds.
Frequently asked about CorFlow Therapeutics AG funding
How much has CorFlow Therapeutics AG raised?
CorFlow Therapeutics AG has raised $60M in total disclosed funding across the rounds on record.
Who has invested in CorFlow Therapeutics AG?
Broadview Ventures, Panakes Partners, 415 Capital, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners are named among the investors backing CorFlow Therapeutics AG.
What was the latest CorFlow Therapeutics AG funding round?
The most recent disclosed round is a Series B, announced in September 2024.
Where is CorFlow Therapeutics AG based?
CorFlow Therapeutics AG is based in Baar, Switzerland.
When did CorFlow Therapeutics AG last raise?
The last disclosed CorFlow Therapeutics AG round closed in September 2024 at Series B.
Every CorFlow Therapeutics AG figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Baar at a similar stage.
